Correlation Between Kezar Life and Galmed Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kezar Life and Galmed Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kezar Life and Galmed Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kezar Life Sciences and Galmed Pharmaceuticals, you can compare the effects of market volatilities on Kezar Life and Galmed Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kezar Life with a short position of Galmed Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kezar Life and Galmed Pharmaceuticals.

Diversification Opportunities for Kezar Life and Galmed Pharmaceuticals

-0.35
  Correlation Coefficient

Very good diversification

The 3 months correlation between Kezar and Galmed is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Kezar Life Sciences and Galmed Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Galmed Pharmaceuticals and Kezar Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kezar Life Sciences are associated (or correlated) with Galmed Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Galmed Pharmaceuticals has no effect on the direction of Kezar Life i.e., Kezar Life and Galmed Pharmaceuticals go up and down completely randomly.

Pair Corralation between Kezar Life and Galmed Pharmaceuticals

Considering the 90-day investment horizon Kezar Life Sciences is expected to under-perform the Galmed Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Kezar Life Sciences is 3.22 times less risky than Galmed Pharmaceuticals. The stock trades about -0.07 of its potential returns per unit of risk. The Galmed Pharmaceuticals is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  5,704  in Galmed Pharmaceuticals on August 26, 2024 and sell it today you would lose (5,429) from holding Galmed Pharmaceuticals or give up 95.18% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Kezar Life Sciences  vs.  Galmed Pharmaceuticals

 Performance 
       Timeline  
Kezar Life Sciences 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Kezar Life Sciences are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Kezar Life reported solid returns over the last few months and may actually be approaching a breakup point.
Galmed Pharmaceuticals 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Galmed Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady primary indicators, Galmed Pharmaceuticals exhibited solid returns over the last few months and may actually be approaching a breakup point.

Kezar Life and Galmed Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kezar Life and Galmed Pharmaceuticals

The main advantage of trading using opposite Kezar Life and Galmed Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kezar Life position performs unexpectedly, Galmed Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Galmed Pharmaceuticals will offset losses from the drop in Galmed Pharmaceuticals' long position.
The idea behind Kezar Life Sciences and Galmed Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Technical Analysis
Check basic technical indicators and analysis based on most latest market data
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm